Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy (LIVELOC)
Rectal Neoplasms, Ostomy, Neoplasms
About this trial
This is an interventional treatment trial for Rectal Neoplasms focused on measuring Rectal cancer, Low anterior resection, Loop transverse colostomy, Loop ileostomy, Stoma site infections
Eligibility Criteria
Inclusion Criteria: Histologically confirmed adenocarcinoma of the rectum (stages 1-3 according to MRI) ECOG status 0-2, ASA≤3. At least 18 years of age Written informed consent Exclusion Criteria: Emergency surgery; Previously formed stoma; Stage 4 disease; Obstructive resection of the rectum; Patients older than 79 years
Sites / Locations
- Republican clinical oncological dispenceryRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Loop transverse colostomy
Loop ileostomy
Laparoscopic or open low-anterior resection of the rectum with total mesorectal excision and created loop transverse colostomy
Laparoscopic or open low-anterior resection of the rectum with total mesorectal excision and created loop ileostomy